GLD vs XERS
SPDR® Gold Shares (GLD) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
GLD does not have a complete income-statement cache yet.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
GLD currently screens at market cap $0. XERS currently screens at market cap $760.7M.
Not investment advice. Open the GLD and XERS stock pages for the full models.
Not investment advice.